Global Multi Cancer Screening Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Multi Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi Cancer Screening.
The Multi Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Multi Cancer Screening market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi Cancer Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Multi Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Multi Cancer Screening market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Guardant Health
- GRAIL
- Burning Rock
- Thermo Fisher Scientific
- Exact Sciences Corporation
- Fulgent Genetics
- Genecast Biotechnology
- Agilent Technologies
- Atara Biotherapeutics
- Konica Minolta
- Tempus
- Myriad Genetics
- Laboratory Corporation
- Laboratory Developed Tests (LDTs)
- In-Vitro Diagnostics (IVDs)
- Hospitals
- Clinic
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi Cancer Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multi Cancer Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Laboratory Developed Tests (LDTs)
1.2.3 In-Vitro Diagnostics (IVDs)
1.3 Market by Application
1.3.1 Global Multi Cancer Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Multi Cancer Screening Market Perspective (2018-2029)
2.2 Multi Cancer Screening Growth Trends by Region
2.2.1 Global Multi Cancer Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multi Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Multi Cancer Screening Forecasted Market Size by Region (2024-2029)
2.3 Multi Cancer Screening Market Dynamics
2.3.1 Multi Cancer Screening Industry Trends
2.3.2 Multi Cancer Screening Market Drivers
2.3.3 Multi Cancer Screening Market Challenges
2.3.4 Multi Cancer Screening Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Multi Cancer Screening Players by Revenue
3.1.1 Global Top Multi Cancer Screening Players by Revenue (2018-2023)
3.1.2 Global Multi Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Multi Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multi Cancer Screening Revenue
3.4 Global Multi Cancer Screening Market Concentration Ratio
3.4.1 Global Multi Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi Cancer Screening Revenue in 2022
3.5 Multi Cancer Screening Key Players Head office and Area Served
3.6 Key Players Multi Cancer Screening Product Solution and Service
3.7 Date of Enter into Multi Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MULTI CANCER SCREENING BREAKDOWN DATA BY TYPE
4.1 Global Multi Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Multi Cancer Screening Forecasted Market Size by Type (2024-2029)
5 MULTI CANCER SCREENING BREAKDOWN DATA BY APPLICATION
5.1 Global Multi Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Multi Cancer Screening Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Multi Cancer Screening Market Size (2018-2029)
6.2 North America Multi Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multi Cancer Screening Market Size by Country (2018-2023)
6.4 North America Multi Cancer Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Multi Cancer Screening Market Size (2018-2029)
7.2 Europe Multi Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multi Cancer Screening Market Size by Country (2018-2023)
7.4 Europe Multi Cancer Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Multi Cancer Screening Market Size (2018-2029)
8.2 Asia-Pacific Multi Cancer Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multi Cancer Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Multi Cancer Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Multi Cancer Screening Market Size (2018-2029)
9.2 Latin America Multi Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multi Cancer Screening Market Size by Country (2018-2023)
9.4 Latin America Multi Cancer Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Multi Cancer Screening Market Size (2018-2029)
10.2 Middle East & Africa Multi Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multi Cancer Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Multi Cancer Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Guardant Health
11.1.1 Guardant Health Company Detail
11.1.2 Guardant Health Business Overview
11.1.3 Guardant Health Multi Cancer Screening Introduction
11.1.4 Guardant Health Revenue in Multi Cancer Screening Business (2018-2023)
11.1.5 Guardant Health Recent Development
11.2 GRAIL
11.2.1 GRAIL Company Detail
11.2.2 GRAIL Business Overview
11.2.3 GRAIL Multi Cancer Screening Introduction
11.2.4 GRAIL Revenue in Multi Cancer Screening Business (2018-2023)
11.2.5 GRAIL Recent Development
11.3 Burning Rock
11.3.1 Burning Rock Company Detail
11.3.2 Burning Rock Business Overview
11.3.3 Burning Rock Multi Cancer Screening Introduction
11.3.4 Burning Rock Revenue in Multi Cancer Screening Business (2018-2023)
11.3.5 Burning Rock Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Multi Cancer Screening Introduction
11.4.4 Thermo Fisher Scientific Revenue in Multi Cancer Screening Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Exact Sciences Corporation
11.5.1 Exact Sciences Corporation Company Detail
11.5.2 Exact Sciences Corporation Business Overview
11.5.3 Exact Sciences Corporation Multi Cancer Screening Introduction
11.5.4 Exact Sciences Corporation Revenue in Multi Cancer Screening Business (2018-2023)
11.5.5 Exact Sciences Corporation Recent Development
11.6 Fulgent Genetics
11.6.1 Fulgent Genetics Company Detail
11.6.2 Fulgent Genetics Business Overview
11.6.3 Fulgent Genetics Multi Cancer Screening Introduction
11.6.4 Fulgent Genetics Revenue in Multi Cancer Screening Business (2018-2023)
11.6.5 Fulgent Genetics Recent Development
11.7 Genecast Biotechnology
11.7.1 Genecast Biotechnology Company Detail
11.7.2 Genecast Biotechnology Business Overview
11.7.3 Genecast Biotechnology Multi Cancer Screening Introduction
11.7.4 Genecast Biotechnology Revenue in Multi Cancer Screening Business (2018-2023)
11.7.5 Genecast Biotechnology Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Multi Cancer Screening Introduction
11.8.4 Agilent Technologies Revenue in Multi Cancer Screening Business (2018-2023)
11.8.5 Agilent Technologies Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Detail
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics Multi Cancer Screening Introduction
11.9.4 Atara Biotherapeutics Revenue in Multi Cancer Screening Business (2018-2023)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Konica Minolta
11.10.1 Konica Minolta Company Detail
11.10.2 Konica Minolta Business Overview
11.10.3 Konica Minolta Multi Cancer Screening Introduction
11.10.4 Konica Minolta Revenue in Multi Cancer Screening Business (2018-2023)
11.10.5 Konica Minolta Recent Development
11.11 Tempus
11.11.1 Tempus Company Detail
11.11.2 Tempus Business Overview
11.11.3 Tempus Multi Cancer Screening Introduction
11.11.4 Tempus Revenue in Multi Cancer Screening Business (2018-2023)
11.11.5 Tempus Recent Development
11.12 Myriad Genetics
11.12.1 Myriad Genetics Company Detail
11.12.2 Myriad Genetics Business Overview
11.12.3 Myriad Genetics Multi Cancer Screening Introduction
11.12.4 Myriad Genetics Revenue in Multi Cancer Screening Business (2018-2023)
11.12.5 Myriad Genetics Recent Development
11.13 Laboratory Corporation
11.13.1 Laboratory Corporation Company Detail
11.13.2 Laboratory Corporation Business Overview
11.13.3 Laboratory Corporation Multi Cancer Screening Introduction
11.13.4 Laboratory Corporation Revenue in Multi Cancer Screening Business (2018-2023)
11.13.5 Laboratory Corporation Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multi Cancer Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Laboratory Developed Tests (LDTs)
1.2.3 In-Vitro Diagnostics (IVDs)
1.3 Market by Application
1.3.1 Global Multi Cancer Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Multi Cancer Screening Market Perspective (2018-2029)
2.2 Multi Cancer Screening Growth Trends by Region
2.2.1 Global Multi Cancer Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multi Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Multi Cancer Screening Forecasted Market Size by Region (2024-2029)
2.3 Multi Cancer Screening Market Dynamics
2.3.1 Multi Cancer Screening Industry Trends
2.3.2 Multi Cancer Screening Market Drivers
2.3.3 Multi Cancer Screening Market Challenges
2.3.4 Multi Cancer Screening Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Multi Cancer Screening Players by Revenue
3.1.1 Global Top Multi Cancer Screening Players by Revenue (2018-2023)
3.1.2 Global Multi Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Multi Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multi Cancer Screening Revenue
3.4 Global Multi Cancer Screening Market Concentration Ratio
3.4.1 Global Multi Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi Cancer Screening Revenue in 2022
3.5 Multi Cancer Screening Key Players Head office and Area Served
3.6 Key Players Multi Cancer Screening Product Solution and Service
3.7 Date of Enter into Multi Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MULTI CANCER SCREENING BREAKDOWN DATA BY TYPE
4.1 Global Multi Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Multi Cancer Screening Forecasted Market Size by Type (2024-2029)
5 MULTI CANCER SCREENING BREAKDOWN DATA BY APPLICATION
5.1 Global Multi Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Multi Cancer Screening Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Multi Cancer Screening Market Size (2018-2029)
6.2 North America Multi Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multi Cancer Screening Market Size by Country (2018-2023)
6.4 North America Multi Cancer Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Multi Cancer Screening Market Size (2018-2029)
7.2 Europe Multi Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multi Cancer Screening Market Size by Country (2018-2023)
7.4 Europe Multi Cancer Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Multi Cancer Screening Market Size (2018-2029)
8.2 Asia-Pacific Multi Cancer Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multi Cancer Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Multi Cancer Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Multi Cancer Screening Market Size (2018-2029)
9.2 Latin America Multi Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multi Cancer Screening Market Size by Country (2018-2023)
9.4 Latin America Multi Cancer Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Multi Cancer Screening Market Size (2018-2029)
10.2 Middle East & Africa Multi Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multi Cancer Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Multi Cancer Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Guardant Health
11.1.1 Guardant Health Company Detail
11.1.2 Guardant Health Business Overview
11.1.3 Guardant Health Multi Cancer Screening Introduction
11.1.4 Guardant Health Revenue in Multi Cancer Screening Business (2018-2023)
11.1.5 Guardant Health Recent Development
11.2 GRAIL
11.2.1 GRAIL Company Detail
11.2.2 GRAIL Business Overview
11.2.3 GRAIL Multi Cancer Screening Introduction
11.2.4 GRAIL Revenue in Multi Cancer Screening Business (2018-2023)
11.2.5 GRAIL Recent Development
11.3 Burning Rock
11.3.1 Burning Rock Company Detail
11.3.2 Burning Rock Business Overview
11.3.3 Burning Rock Multi Cancer Screening Introduction
11.3.4 Burning Rock Revenue in Multi Cancer Screening Business (2018-2023)
11.3.5 Burning Rock Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Multi Cancer Screening Introduction
11.4.4 Thermo Fisher Scientific Revenue in Multi Cancer Screening Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Exact Sciences Corporation
11.5.1 Exact Sciences Corporation Company Detail
11.5.2 Exact Sciences Corporation Business Overview
11.5.3 Exact Sciences Corporation Multi Cancer Screening Introduction
11.5.4 Exact Sciences Corporation Revenue in Multi Cancer Screening Business (2018-2023)
11.5.5 Exact Sciences Corporation Recent Development
11.6 Fulgent Genetics
11.6.1 Fulgent Genetics Company Detail
11.6.2 Fulgent Genetics Business Overview
11.6.3 Fulgent Genetics Multi Cancer Screening Introduction
11.6.4 Fulgent Genetics Revenue in Multi Cancer Screening Business (2018-2023)
11.6.5 Fulgent Genetics Recent Development
11.7 Genecast Biotechnology
11.7.1 Genecast Biotechnology Company Detail
11.7.2 Genecast Biotechnology Business Overview
11.7.3 Genecast Biotechnology Multi Cancer Screening Introduction
11.7.4 Genecast Biotechnology Revenue in Multi Cancer Screening Business (2018-2023)
11.7.5 Genecast Biotechnology Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Multi Cancer Screening Introduction
11.8.4 Agilent Technologies Revenue in Multi Cancer Screening Business (2018-2023)
11.8.5 Agilent Technologies Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Detail
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics Multi Cancer Screening Introduction
11.9.4 Atara Biotherapeutics Revenue in Multi Cancer Screening Business (2018-2023)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Konica Minolta
11.10.1 Konica Minolta Company Detail
11.10.2 Konica Minolta Business Overview
11.10.3 Konica Minolta Multi Cancer Screening Introduction
11.10.4 Konica Minolta Revenue in Multi Cancer Screening Business (2018-2023)
11.10.5 Konica Minolta Recent Development
11.11 Tempus
11.11.1 Tempus Company Detail
11.11.2 Tempus Business Overview
11.11.3 Tempus Multi Cancer Screening Introduction
11.11.4 Tempus Revenue in Multi Cancer Screening Business (2018-2023)
11.11.5 Tempus Recent Development
11.12 Myriad Genetics
11.12.1 Myriad Genetics Company Detail
11.12.2 Myriad Genetics Business Overview
11.12.3 Myriad Genetics Multi Cancer Screening Introduction
11.12.4 Myriad Genetics Revenue in Multi Cancer Screening Business (2018-2023)
11.12.5 Myriad Genetics Recent Development
11.13 Laboratory Corporation
11.13.1 Laboratory Corporation Company Detail
11.13.2 Laboratory Corporation Business Overview
11.13.3 Laboratory Corporation Multi Cancer Screening Introduction
11.13.4 Laboratory Corporation Revenue in Multi Cancer Screening Business (2018-2023)
11.13.5 Laboratory Corporation Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Multi Cancer Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Laboratory Developed Tests (LDTs)
Table 3. Key Players of In-Vitro Diagnostics (IVDs)
Table 4. Global Multi Cancer Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Multi Cancer Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Multi Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Multi Cancer Screening Market Share by Region (2018-2023)
Table 8. Global Multi Cancer Screening Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Multi Cancer Screening Market Share by Region (2024-2029)
Table 10. Multi Cancer Screening Market Trends
Table 11. Multi Cancer Screening Market Drivers
Table 12. Multi Cancer Screening Market Challenges
Table 13. Multi Cancer Screening Market Restraints
Table 14. Global Multi Cancer Screening Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Multi Cancer Screening Market Share by Players (2018-2023)
Table 16. Global Top Multi Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi Cancer Screening as of 2022)
Table 17. Ranking of Global Top Multi Cancer Screening Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Multi Cancer Screening Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Multi Cancer Screening Product Solution and Service
Table 21. Date of Enter into Multi Cancer Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Multi Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Multi Cancer Screening Revenue Market Share by Type (2018-2023)
Table 25. Global Multi Cancer Screening Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Multi Cancer Screening Revenue Market Share by Type (2024-2029)
Table 27. Global Multi Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Multi Cancer Screening Revenue Market Share by Application (2018-2023)
Table 29. Global Multi Cancer Screening Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Multi Cancer Screening Revenue Market Share by Application (2024-2029)
Table 31. North America Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Multi Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Multi Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Multi Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Multi Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Multi Cancer Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Multi Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Multi Cancer Screening Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Multi Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Multi Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Multi Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Multi Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 46. Guardant Health Company Detail
Table 47. Guardant Health Business Overview
Table 48. Guardant Health Multi Cancer Screening Product
Table 49. Guardant Health Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 50. Guardant Health Recent Development
Table 51. GRAIL Company Detail
Table 52. GRAIL Business Overview
Table 53. GRAIL Multi Cancer Screening Product
Table 54. GRAIL Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 55. GRAIL Recent Development
Table 56. Burning Rock Company Detail
Table 57. Burning Rock Business Overview
Table 58. Burning Rock Multi Cancer Screening Product
Table 59. Burning Rock Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 60. Burning Rock Recent Development
Table 61. Thermo Fisher Scientific Company Detail
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Multi Cancer Screening Product
Table 64. Thermo Fisher Scientific Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Exact Sciences Corporation Company Detail
Table 67. Exact Sciences Corporation Business Overview
Table 68. Exact Sciences Corporation Multi Cancer Screening Product
Table 69. Exact Sciences Corporation Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 70. Exact Sciences Corporation Recent Development
Table 71. Fulgent Genetics Company Detail
Table 72. Fulgent Genetics Business Overview
Table 73. Fulgent Genetics Multi Cancer Screening Product
Table 74. Fulgent Genetics Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 75. Fulgent Genetics Recent Development
Table 76. Genecast Biotechnology Company Detail
Table 77. Genecast Biotechnology Business Overview
Table 78. Genecast Biotechnology Multi Cancer Screening Product
Table 79. Genecast Biotechnology Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 80. Genecast Biotechnology Recent Development
Table 81. Agilent Technologies Company Detail
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies Multi Cancer Screening Product
Table 84. Agilent Technologies Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 85. Agilent Technologies Recent Development
Table 86. Atara Biotherapeutics Company Detail
Table 87. Atara Biotherapeutics Business Overview
Table 88. Atara Biotherapeutics Multi Cancer Screening Product
Table 89. Atara Biotherapeutics Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 90. Atara Biotherapeutics Recent Development
Table 91. Konica Minolta Company Detail
Table 92. Konica Minolta Business Overview
Table 93. Konica Minolta Multi Cancer Screening Product
Table 94. Konica Minolta Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 95. Konica Minolta Recent Development
Table 96. Tempus Company Detail
Table 97. Tempus Business Overview
Table 98. Tempus Multi Cancer Screening Product
Table 99. Tempus Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 100. Tempus Recent Development
Table 101. Myriad Genetics Company Detail
Table 102. Myriad Genetics Business Overview
Table 103. Myriad Genetics Multi Cancer Screening Product
Table 104. Myriad Genetics Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 105. Myriad Genetics Recent Development
Table 106. Laboratory Corporation Company Detail
Table 107. Laboratory Corporation Business Overview
Table 108. Laboratory Corporation Multi Cancer Screening Product
Table 109. Laboratory Corporation Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 110. Laboratory Corporation Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 1. Global Multi Cancer Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Laboratory Developed Tests (LDTs)
Table 3. Key Players of In-Vitro Diagnostics (IVDs)
Table 4. Global Multi Cancer Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Multi Cancer Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Multi Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Multi Cancer Screening Market Share by Region (2018-2023)
Table 8. Global Multi Cancer Screening Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Multi Cancer Screening Market Share by Region (2024-2029)
Table 10. Multi Cancer Screening Market Trends
Table 11. Multi Cancer Screening Market Drivers
Table 12. Multi Cancer Screening Market Challenges
Table 13. Multi Cancer Screening Market Restraints
Table 14. Global Multi Cancer Screening Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Multi Cancer Screening Market Share by Players (2018-2023)
Table 16. Global Top Multi Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi Cancer Screening as of 2022)
Table 17. Ranking of Global Top Multi Cancer Screening Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Multi Cancer Screening Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Multi Cancer Screening Product Solution and Service
Table 21. Date of Enter into Multi Cancer Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Multi Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Multi Cancer Screening Revenue Market Share by Type (2018-2023)
Table 25. Global Multi Cancer Screening Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Multi Cancer Screening Revenue Market Share by Type (2024-2029)
Table 27. Global Multi Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Multi Cancer Screening Revenue Market Share by Application (2018-2023)
Table 29. Global Multi Cancer Screening Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Multi Cancer Screening Revenue Market Share by Application (2024-2029)
Table 31. North America Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Multi Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Multi Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Multi Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Multi Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Multi Cancer Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Multi Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Multi Cancer Screening Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Multi Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Multi Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Multi Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Multi Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 46. Guardant Health Company Detail
Table 47. Guardant Health Business Overview
Table 48. Guardant Health Multi Cancer Screening Product
Table 49. Guardant Health Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 50. Guardant Health Recent Development
Table 51. GRAIL Company Detail
Table 52. GRAIL Business Overview
Table 53. GRAIL Multi Cancer Screening Product
Table 54. GRAIL Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 55. GRAIL Recent Development
Table 56. Burning Rock Company Detail
Table 57. Burning Rock Business Overview
Table 58. Burning Rock Multi Cancer Screening Product
Table 59. Burning Rock Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 60. Burning Rock Recent Development
Table 61. Thermo Fisher Scientific Company Detail
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Multi Cancer Screening Product
Table 64. Thermo Fisher Scientific Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Exact Sciences Corporation Company Detail
Table 67. Exact Sciences Corporation Business Overview
Table 68. Exact Sciences Corporation Multi Cancer Screening Product
Table 69. Exact Sciences Corporation Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 70. Exact Sciences Corporation Recent Development
Table 71. Fulgent Genetics Company Detail
Table 72. Fulgent Genetics Business Overview
Table 73. Fulgent Genetics Multi Cancer Screening Product
Table 74. Fulgent Genetics Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 75. Fulgent Genetics Recent Development
Table 76. Genecast Biotechnology Company Detail
Table 77. Genecast Biotechnology Business Overview
Table 78. Genecast Biotechnology Multi Cancer Screening Product
Table 79. Genecast Biotechnology Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 80. Genecast Biotechnology Recent Development
Table 81. Agilent Technologies Company Detail
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies Multi Cancer Screening Product
Table 84. Agilent Technologies Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 85. Agilent Technologies Recent Development
Table 86. Atara Biotherapeutics Company Detail
Table 87. Atara Biotherapeutics Business Overview
Table 88. Atara Biotherapeutics Multi Cancer Screening Product
Table 89. Atara Biotherapeutics Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 90. Atara Biotherapeutics Recent Development
Table 91. Konica Minolta Company Detail
Table 92. Konica Minolta Business Overview
Table 93. Konica Minolta Multi Cancer Screening Product
Table 94. Konica Minolta Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 95. Konica Minolta Recent Development
Table 96. Tempus Company Detail
Table 97. Tempus Business Overview
Table 98. Tempus Multi Cancer Screening Product
Table 99. Tempus Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 100. Tempus Recent Development
Table 101. Myriad Genetics Company Detail
Table 102. Myriad Genetics Business Overview
Table 103. Myriad Genetics Multi Cancer Screening Product
Table 104. Myriad Genetics Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 105. Myriad Genetics Recent Development
Table 106. Laboratory Corporation Company Detail
Table 107. Laboratory Corporation Business Overview
Table 108. Laboratory Corporation Multi Cancer Screening Product
Table 109. Laboratory Corporation Revenue in Multi Cancer Screening Business (2018-2023) & (US$ Million)
Table 110. Laboratory Corporation Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Multi Cancer Screening Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Multi Cancer Screening Market Share by Type: 2022 VS 2029
Figure 3. Laboratory Developed Tests (LDTs) Features
Figure 4. In-Vitro Diagnostics (IVDs) Features
Figure 5. Global Multi Cancer Screening Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Multi Cancer Screening Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Multi Cancer Screening Report Years Considered
Figure 10. Global Multi Cancer Screening Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Multi Cancer Screening Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Multi Cancer Screening Market Share by Region: 2022 VS 2029
Figure 13. Global Multi Cancer Screening Market Share by Players in 2022
Figure 14. Global Top Multi Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi Cancer Screening as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Multi Cancer Screening Revenue in 2022
Figure 16. North America Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Multi Cancer Screening Market Share by Country (2018-2029)
Figure 18. United States Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Multi Cancer Screening Market Share by Country (2018-2029)
Figure 22. Germany Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Multi Cancer Screening Market Share by Region (2018-2029)
Figure 30. China Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Multi Cancer Screening Market Share by Country (2018-2029)
Figure 38. Mexico Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Multi Cancer Screening Market Share by Country (2018-2029)
Figure 42. Turkey Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Guardant Health Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 45. GRAIL Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 46. Burning Rock Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 48. Exact Sciences Corporation Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 49. Fulgent Genetics Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 50. Genecast Biotechnology Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 51. Agilent Technologies Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 52. Atara Biotherapeutics Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 53. Konica Minolta Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 54. Tempus Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 55. Myriad Genetics Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 56. Laboratory Corporation Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Figure 1. Global Multi Cancer Screening Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Multi Cancer Screening Market Share by Type: 2022 VS 2029
Figure 3. Laboratory Developed Tests (LDTs) Features
Figure 4. In-Vitro Diagnostics (IVDs) Features
Figure 5. Global Multi Cancer Screening Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Multi Cancer Screening Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Multi Cancer Screening Report Years Considered
Figure 10. Global Multi Cancer Screening Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Multi Cancer Screening Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Multi Cancer Screening Market Share by Region: 2022 VS 2029
Figure 13. Global Multi Cancer Screening Market Share by Players in 2022
Figure 14. Global Top Multi Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi Cancer Screening as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Multi Cancer Screening Revenue in 2022
Figure 16. North America Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Multi Cancer Screening Market Share by Country (2018-2029)
Figure 18. United States Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Multi Cancer Screening Market Share by Country (2018-2029)
Figure 22. Germany Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Multi Cancer Screening Market Share by Region (2018-2029)
Figure 30. China Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Multi Cancer Screening Market Share by Country (2018-2029)
Figure 38. Mexico Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Multi Cancer Screening Market Share by Country (2018-2029)
Figure 42. Turkey Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Multi Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Guardant Health Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 45. GRAIL Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 46. Burning Rock Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 48. Exact Sciences Corporation Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 49. Fulgent Genetics Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 50. Genecast Biotechnology Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 51. Agilent Technologies Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 52. Atara Biotherapeutics Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 53. Konica Minolta Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 54. Tempus Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 55. Myriad Genetics Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 56. Laboratory Corporation Revenue Growth Rate in Multi Cancer Screening Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
